Help
RSS
API
Feed
Maltego
Contact
Domain > www.opdualag.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-04-28
45.60.150.161
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyServer: CloudFrontDate: Tue, 20 Aug 2024 22:09:41 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveLocation: https://www.opdualag.com/X-Cache: Redirect html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>CloudFront/center>/body>/html>
Port 443
HTTP/1.1 200 OKContent-Type: text/html;charsetutf-8Connection: keep-aliveDate: Tue, 20 Aug 2024 22:09:41 GMTServer: ApacheX-Content-Type-Options: nosniffAccept-Ranges: bytesX-Dispatcher: dispatcher3us !DOCTYPE HTML>html langen> head> meta nameviewport contentwidthdevice-width, initial-scale1.0/> meta charsetUTF-8/>!--/ Commercial Code integration starts here/--> meta nametitle contentAdvanced Melanoma Treatment | Opdualag™ (nivolumab and relatlimab-rmbw)>meta namedescription contentOpdualag™ (nivolumab and relatlimab-rmbw) is an advanced melanoma treatment option that can help the immune system to fight advanced melanoma. Please see Indication and Important Safety Information.>meta propertyog:title contentAdvanced Melanoma Treatment | Opdualag™ (nivolumab and relatlimab-rmbw) />meta propertyog:site_name contentOpdualag™ (nivolumab and relatlimab-rmbw) Patient Site />meta propertyog:url contenthttps://www.opdualag.com/ />meta propertyog:description contentOpdualag™ (nivolumab and relatlimab-rmbw) is an advanced melanoma treatment option that can help the immune system to fight advanced melanoma. Please see Indication and Important Safety Information. />meta propertyog:type contentwebsite />meta propertyog:image contenthttps://www.opdualag.com/content/dam/commercial/us/opdualagdtc/en/images/OPDUALAG_Logo_Header.svg />link relcanonical hrefhttps://www.opdualag.com />meta namegoogle-site-verification content2h9i-0KRNObRqQ6Eue8T3ngEGs5krw0M-d_cs5bLChw /> meta namekeywords/> title>Advanced Melanoma Treatment | Opdualag™ (nivolumab and relatlimab-rmbw)/title> link relalternate hrefhttps://www.opdualag.com/ />link relalternate hrefhttps://www.opdualag.com/ />link relalternate hrefhttps://www.opdualag.com/es />link href/content/dam/commercial/us/opdualagdtc/en/images/favicon.png relshortcut icon/>script typeapplication/ld+json> { @context: http://schema.org, @type: MedicalWebPage, audience: { @type: MedicalAudience, audiencetype: Patient, healthCondition: { @type: MedicalCondition, name: advanced melanoma } } , keywords: opdualag, nivolum
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]